Alternatives to Slate Medicines

Slate Medicines is a Biotechnology tool: advancing anti-PACAP therapies for the prevention of migraine and other headache disorders. Here are the 52 closest alternatives, compared on pricing, features and what real users say.

Slate Medicines profile More Biotechnology alternatives

The 20 closest Biotechnology companies to Slate Medicines

Moderna
2.5 out of 5 (2)
Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
Visit site
CRISPR Therapeutics
Not rated
Biotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology.
Visit site
Infinimmune
Not rated
Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.
Visit site
Adcendo
Not rated
Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.
Visit site
CellCentric
Not rated
A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.
Visit site
Immitra Bio
Not rated
Scalable, one-time curative in-vivo gene editing therapies.
Visit site
mbiomics
Not rated
Advancing scalable microbiome-based therapeutics for severe and chronic diseases.
Visit site
ImmunityBio
Not rated
A commercial-stage immunotherapy company developing novel treatments for cancer and infectious diseases.
Visit site
BioNTech
Not rated
Global biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases.
Visit site
JU
Juno Therapeutics
Not rated
Biotechnology company focused on developing cancer immunotherapies.
Kite Pharma
Not rated
Biotechnology company developing and commercializing cell therapies for cancer treatment.
Visit site
Epicrispr Biotechnologies
Not rated
Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).
Visit site
Seaport Therapeutics
Not rated
Developing novel therapeutics to restore gut lymphatic function.
Visit site
Degron Therapeutics
Not rated
Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.
Visit site
Supernus Pharmaceuticals
Not rated
Biopharmaceutical company developing and commercializing CNS disease treatments.
Visit site
Enterome
Not rated
Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.
Visit site
CR
Create Medicines
Not rated
Developing in vivo immunotherapies for autoimmune diseases and cancer.
LifeMine Therapeutics Inc.
Not rated
Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.
Visit site
Celerion
Not rated
A global leader in clinical pharmacology and bioanalytical sciences.
Visit site
Mironid
Not rated
Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).
Visit site

Company	Rating	Visit
ModernaModerna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.	2.5 out of 5 (2)	Visit site
CRISPR TherapeuticsBiotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology.	Not rated	Visit site
InfinimmuneDeveloping human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.	Not rated	Visit site
AdcendoDeveloping first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.	Not rated	Visit site
CellCentricA clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.	Not rated	Visit site
Immitra BioScalable, one-time curative in-vivo gene editing therapies.	Not rated	Visit site
mbiomicsAdvancing scalable microbiome-based therapeutics for severe and chronic diseases.	Not rated	Visit site
ImmunityBioA commercial-stage immunotherapy company developing novel treatments for cancer and infectious diseases.	Not rated	Visit site
BioNTechGlobal biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases.	Not rated	Visit site
JUJuno TherapeuticsBiotechnology company focused on developing cancer immunotherapies.	Not rated
Kite PharmaBiotechnology company developing and commercializing cell therapies for cancer treatment.	Not rated	Visit site
Epicrispr BiotechnologiesEpicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).	Not rated	Visit site
Seaport TherapeuticsDeveloping novel therapeutics to restore gut lymphatic function.	Not rated	Visit site
Degron TherapeuticsClinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.	Not rated	Visit site
Supernus PharmaceuticalsBiopharmaceutical company developing and commercializing CNS disease treatments.	Not rated	Visit site
EnteromeClinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.	Not rated	Visit site
CRCreate MedicinesDeveloping in vivo immunotherapies for autoimmune diseases and cancer.	Not rated
LifeMine Therapeutics Inc.Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.	Not rated	Visit site
CelerionA global leader in clinical pharmacology and bioanalytical sciences.	Not rated	Visit site
MironidBiopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).	Not rated	Visit site

Showing the next 20 closest matches. See the rest on the Slate Medicines profile.